Rhumbline Advisers Has $21.50 Million Position in Cooper Companies Inc (COO)

Rhumbline Advisers grew its position in shares of Cooper Companies Inc (NYSE:COO) by 0.9% during the 4th quarter, according to the company in its most recent filing with the SEC. The firm owned 98,684 shares of the medical device company’s stock after purchasing an additional 888 shares during the quarter. Rhumbline Advisers’ holdings in Cooper Companies were worth $21,501,000 as of its most recent filing with the SEC.

Several other hedge funds have also recently modified their holdings of the company. Arizona State Retirement System increased its position in shares of Cooper Companies by 4.4% during the 4th quarter. Arizona State Retirement System now owns 47,637 shares of the medical device company’s stock valued at $10,379,000 after purchasing an additional 2,000 shares during the period. Capital Fund Management S.A. increased its position in shares of Cooper Companies by 1,219.6% during the 4th quarter. Capital Fund Management S.A. now owns 61,453 shares of the medical device company’s stock valued at $13,389,000 after purchasing an additional 56,796 shares during the period. Pinebridge Investments L.P. increased its position in shares of Cooper Companies by 258.0% during the 4th quarter. Pinebridge Investments L.P. now owns 8,531 shares of the medical device company’s stock valued at $1,859,000 after purchasing an additional 6,148 shares during the period. Toronto Dominion Bank increased its position in shares of Cooper Companies by 13.9% during the 4th quarter. Toronto Dominion Bank now owns 21,117 shares of the medical device company’s stock valued at $4,600,000 after purchasing an additional 2,581 shares during the period. Finally, The Manufacturers Life Insurance Company increased its position in shares of Cooper Companies by 8.4% during the 4th quarter. The Manufacturers Life Insurance Company now owns 263,312 shares of the medical device company’s stock valued at $57,371,000 after purchasing an additional 20,376 shares during the period. Institutional investors own 95.04% of the company’s stock.

Several equities analysts have recently issued reports on COO shares. Zacks Investment Research cut Cooper Companies from a “buy” rating to a “hold” rating in a research report on Wednesday, November 1st. Stifel Nicolaus reiterated a “buy” rating and set a $265.00 price target (down from $275.00) on shares of Cooper Companies in a research report on Friday, December 8th. Cleveland Research cut Cooper Companies from a “buy” rating to a “hold” rating in a research report on Friday, February 9th. Oppenheimer set a $250.00 price target on Cooper Companies and gave the company a “hold” rating in a research report on Friday, December 8th. Finally, Raymond James Financial reiterated a “buy” rating and set a $265.00 price target on shares of Cooper Companies in a research report on Monday, December 4th. Eight equities research analysts have rated the stock with a hold rating and six have issued a buy rating to the stock. The company has an average rating of “Hold” and an average price target of $259.70.

Cooper Companies Inc (NYSE COO) opened at $230.54 on Friday. The company has a quick ratio of 1.26, a current ratio of 2.41 and a debt-to-equity ratio of 0.36. The stock has a market capitalization of $11,175.40, a price-to-earnings ratio of 30.66, a P/E/G ratio of 1.83 and a beta of 0.57. Cooper Companies Inc has a 1-year low of $191.64 and a 1-year high of $256.39.

Cooper Companies (NYSE:COO) last issued its earnings results on Thursday, December 7th. The medical device company reported $2.65 earnings per share (EPS) for the quarter, topping the Zacks’ consensus estimate of $2.64 by $0.01. The business had revenue of $561.50 million for the quarter, compared to analysts’ expectations of $558.86 million. Cooper Companies had a return on equity of 16.02% and a net margin of 17.43%. The company’s quarterly revenue was up 8.3% on a year-over-year basis. During the same period in the previous year, the firm posted $2.28 EPS. analysts anticipate that Cooper Companies Inc will post 11.57 earnings per share for the current fiscal year.

The business also recently announced a semiannual dividend, which was paid on Friday, February 9th. Investors of record on Tuesday, January 23rd were issued a $0.03 dividend. This represents a dividend yield of 0.03%. The ex-dividend date was Monday, January 22nd. Cooper Companies’s payout ratio is 0.80%.

In related news, Director Allan E. Rubenstein sold 500 shares of Cooper Companies stock in a transaction on Wednesday, December 27th. The stock was sold at an average price of $222.00, for a total value of $111,000.00. Following the transaction, the director now directly owns 6,590 shares in the company, valued at approximately $1,462,980. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, Director Stanley Md Zinberg sold 5,000 shares of Cooper Companies stock in a transaction on Thursday, January 4th. The stock was sold at an average price of $224.66, for a total value of $1,123,300.00. Following the completion of the transaction, the director now owns 6,090 shares in the company, valued at $1,368,179.40. The disclosure for this sale can be found here. Insiders sold a total of 54,385 shares of company stock worth $12,289,463 over the last 90 days. Insiders own 1.60% of the company’s stock.

TRADEMARK VIOLATION NOTICE: “Rhumbline Advisers Has $21.50 Million Position in Cooper Companies Inc (COO)” was originally reported by The Ledger Gazette and is owned by of The Ledger Gazette. If you are accessing this story on another site, it was illegally stolen and reposted in violation of international copyright legislation. The legal version of this story can be viewed at https://ledgergazette.com/2018/02/24/rhumbline-advisers-has-21-50-million-position-in-cooper-companies-inc-coo.html.

About Cooper Companies

The Cooper Companies, Inc is a global medical device company. The Company operates through two business units: CooperVision, Inc and CooperSurgical, Inc CooperVision offers soft contact lenses for the vision correction market. CooperVision develops, manufactures and markets a range of single-use, two-week and monthly contact lenses.

Want to see what other hedge funds are holding COO? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Cooper Companies Inc (NYSE:COO).

Institutional Ownership by Quarter for Cooper Companies (NYSE:COO)

Receive News & Ratings for Cooper Companies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cooper Companies and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply